Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells
- 1 March 2003
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 464 (2-3) , 207-215
- https://doi.org/10.1016/s0014-2999(03)01379-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein couplingFEBS Letters, 1995
- Cannabinoids enhance human B‐cell growth at low nanomolar concentrationsFEBS Letters, 1995
- Pharmacology of Cannabinoid ReceptorsAnnual Review of Pharmacology and Toxicology, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulatorsInternational Journal of Immunopharmacology, 1992
- Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitroInternational Journal of Immunopharmacology, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Organ selectivity of drugs Alternatives to receptor selectivityTrends in Pharmacological Sciences, 1982